EGFR and neoplasm: For example, β1 integrin silencing in human NSCLC A549 cells showed a defective activation of the EGFR signaling cascade, resulting in enhanced sensitivity to Gefitinib and cisplatin, reduced migration, and invasive behavior, and decreased in vitro proliferation and in vivo tumor growth.